vs
Side-by-side financial comparison of ELECTRO SENSORS INC (ELSE) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.
Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $2.8M, roughly 1.4× ELECTRO SENSORS INC). On growth, ELECTRO SENSORS INC posted the faster year-over-year revenue change (14.8% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs 10.8%).
Polar Electro Oy is a Finnish manufacturer of sports training computers, particularly known for developing the world's first wireless heart rate monitor.
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
ELSE vs IRD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.8M | $3.9M |
| Net Profit | $103.0K | — |
| Gross Margin | 50.3% | — |
| Operating Margin | -0.3% | — |
| Net Margin | 3.7% | — |
| Revenue YoY | 14.8% | -10.2% |
| Net Profit YoY | -48.8% | 53.0% |
| EPS (diluted) | $0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.8M | $3.9M | ||
| Q3 25 | $2.7M | $3.1M | ||
| Q2 25 | $2.4M | $2.9M | ||
| Q1 25 | $2.2M | $4.4M | ||
| Q4 24 | $2.4M | $4.3M | ||
| Q3 24 | $2.5M | $3.9M | ||
| Q2 24 | $2.2M | $1.1M | ||
| Q1 24 | $2.2M | $1.7M |
| Q4 25 | $103.0K | — | ||
| Q3 25 | $208.0K | $-17.5M | ||
| Q2 25 | $59.0K | $-7.4M | ||
| Q1 25 | $-64.0K | $-8.2M | ||
| Q4 24 | $201.0K | — | ||
| Q3 24 | $238.0K | $-7.5M | ||
| Q2 24 | $-4.0K | $-7.8M | ||
| Q1 24 | $11.0K | $-7.1M |
| Q4 25 | 50.3% | — | ||
| Q3 25 | 53.1% | — | ||
| Q2 25 | 51.2% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | 49.6% | — | ||
| Q3 24 | 50.4% | — | ||
| Q2 24 | 47.2% | — | ||
| Q1 24 | 48.1% | — |
| Q4 25 | -0.3% | — | ||
| Q3 25 | 6.6% | -269.9% | ||
| Q2 25 | -0.1% | -309.0% | ||
| Q1 25 | -7.5% | -227.2% | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 6.9% | -207.1% | ||
| Q2 24 | -4.8% | -748.9% | ||
| Q1 24 | -4.5% | -450.5% |
| Q4 25 | 3.7% | — | ||
| Q3 25 | 7.6% | -566.9% | ||
| Q2 25 | 2.5% | -257.5% | ||
| Q1 25 | -2.9% | -187.5% | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 9.5% | -194.6% | ||
| Q2 24 | -0.2% | -698.3% | ||
| Q1 24 | 0.5% | -415.3% |
| Q4 25 | $0.03 | — | ||
| Q3 25 | $0.06 | $-0.25 | ||
| Q2 25 | $0.02 | $-0.12 | ||
| Q1 25 | $-0.02 | $-0.24 | ||
| Q4 24 | $0.06 | — | ||
| Q3 24 | $0.07 | $-0.29 | ||
| Q2 24 | $0.00 | $-0.30 | ||
| Q1 24 | $0.00 | $-0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.6M | $45.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $14.8M | $15.3M |
| Total Assets | $15.7M | $50.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.6M | $45.1M | ||
| Q3 25 | $10.6M | $30.8M | ||
| Q2 25 | $10.2M | $32.4M | ||
| Q1 25 | $10.0M | $41.8M | ||
| Q4 24 | $10.0M | $30.3M | ||
| Q3 24 | $10.3M | $36.6M | ||
| Q2 24 | $9.9M | $41.4M | ||
| Q1 24 | $10.1M | $47.2M |
| Q4 25 | $14.8M | $15.3M | ||
| Q3 25 | $14.7M | $6.0M | ||
| Q2 25 | $14.4M | $17.5M | ||
| Q1 25 | $14.3M | $5.1M | ||
| Q4 24 | $14.3M | $6.7M | ||
| Q3 24 | $14.1M | $34.3M | ||
| Q2 24 | $13.8M | $40.6M | ||
| Q1 24 | $13.8M | $46.1M |
| Q4 25 | $15.7M | $50.2M | ||
| Q3 25 | $15.7M | $36.1M | ||
| Q2 25 | $15.2M | $38.7M | ||
| Q1 25 | $15.1M | $48.2M | ||
| Q4 24 | $14.9M | $36.9M | ||
| Q3 24 | $15.0M | $40.4M | ||
| Q2 24 | $14.5M | $44.8M | ||
| Q1 24 | $14.5M | $51.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.0K | $-35.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.0K | $-35.3M | ||
| Q3 25 | $395.0K | $-6.2M | ||
| Q2 25 | $277.0K | $-10.3M | ||
| Q1 25 | $-30.0K | $-9.0M | ||
| Q4 24 | $-277.0K | $-25.6M | ||
| Q3 24 | $362.0K | $-5.1M | ||
| Q2 24 | $-158.0K | $-7.3M | ||
| Q1 24 | $202.0K | $-5.7M |
| Q4 25 | — | — | ||
| Q3 25 | $389.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-298.0K | — | ||
| Q3 24 | $358.0K | — | ||
| Q2 24 | $-184.0K | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -12.4% | — | ||
| Q3 24 | 14.3% | — | ||
| Q2 24 | -8.3% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 0.0% | — |
| Q4 25 | 0.19× | — | ||
| Q3 25 | 1.90× | — | ||
| Q2 25 | 4.69× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -1.38× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 18.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
